Elite Pharmaceuticals Inc (ELTP): Shares Outstanding

Annual figures by period end, from SEC filings.

1.08B
As of 2026-03-31
1.08B
As of 2026-06-30
+2.0%
3-year compound annual growth
+1.3%
5-year compound annual growth
+4.2%
10-year compound annual growth
2011-03-31: 180.55M2012-03-31: 331.65M2013-03-31: 374.39M2014-03-31: 560.14M2015-03-31: 631.06M2016-03-31: 711.44M2017-03-31: 927.93M2018-03-31: 802.53M2019-03-31: 824.85M2020-03-31: 840.40M2021-03-31: 1.01B2022-03-31: 1.01B2023-03-31: 1.01B2024-03-31: 1.07B2025-03-31: 1.07B2026-03-31: 1.08B1.08B
2011-03-31 Shares Outstanding (shares) 2026-03-31
Period endedShares OutstandingChange YoYSource filing
2026-03-311.08B+0.8%2026-06-29, Balance as of period end
2025-03-311.07B0.0%2026-06-29, Balance as of period end
2024-03-311.07B+5.4%2025-06-30, Balance as of period end
2023-03-311.01B+0.3%2024-07-01, Balance as of period end
2022-03-311.01B+0.2%2023-06-29, Balance as of period end
2021-03-311.01B+20.1%2022-06-29, Balance as of period end
2020-03-31840.40M+1.9%2021-06-14, Balance as of period end
2019-03-31824.85M+2.8%2020-06-29, Balance as of period end
2018-03-31802.53M-13.5%2019-06-21, Balance as of period end
2017-03-31927.93M+30.4%2018-06-14, Balance as of period end
2016-03-31711.44M+12.7%2017-06-14, Balance as of period end
2015-03-31631.06M+12.7%2016-06-15, Balance as of period end
2014-03-31560.14Mn/c2015-06-15, Balance as of period end
2013-03-31374.39M+12.9%2014-06-30, Balance as of period end
2012-03-31331.65M+83.7%2013-06-21, Balance as of period end
2011-03-31180.55Mn/a2012-06-29, Balance as of period end